• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多价辅助控制细胞内信号通路:在泛素依赖性N端规则途径中的应用

Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin- dependent N-end rule pathway.

作者信息

Sriram Shashikanth M, Banerjee Rajkumar, Kane Ravi S, Kwon Yong Tae

机构信息

Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

Chem Biol. 2009 Feb 27;16(2):121-31. doi: 10.1016/j.chembiol.2009.01.012.

DOI:10.1016/j.chembiol.2009.01.012
PMID:19246002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2665046/
Abstract

Intracellular signaling is often mediated by a family of functionally overlapping signal mediators that contain multiple sites interacting with other proteins or ligands with weak affinity (K(d) > microM). Conjugation of multiple low-affinity ligands into a high-affinity multivalent molecule provides a means to control the entire protein family within a single intracellular pathway. The N-end rule pathway is a ubiquitin (Ub)-dependent proteolytic system where at least four Ub ligases, called N-recognins, have a common domain critical for binding to type 1 (basic) and type 2 (bulky hydrophobic) destabilizing N-terminal residues of substrates as degrons. The recent development of a heterodivalent inhibitor targeting type 1 and type 2 substrate binding sites of the N-recognin family provides new opportunities to manipulate this proteolytic pathway in biochemical and pathophysiological conditions. We overview the N-end rule pathway as an intracellular target for heterodivalent molecules and discuss the basis of thermodynamics and kinetics related to heterodivalent interactions.

摘要

细胞内信号传导通常由一类功能重叠的信号介质介导,这些信号介质包含多个与其他蛋白质或配体以弱亲和力(K(d) > microM)相互作用的位点。将多个低亲和力配体缀合成一个高亲和力的多价分子,为在单个细胞内途径中控制整个蛋白质家族提供了一种方法。N端规则途径是一种依赖泛素(Ub)的蛋白水解系统,其中至少有四种Ub连接酶,称为N识别蛋白,具有一个共同结构域,该结构域对于结合作为降解子的底物的1型(碱性)和2型(大体积疏水)不稳定N端残基至关重要。靶向N识别蛋白家族1型和2型底物结合位点的异二价抑制剂的最新进展,为在生化和病理生理条件下操纵这一蛋白水解途径提供了新机会。我们概述了N端规则途径作为异二价分子的细胞内靶点,并讨论了与异二价相互作用相关的热力学和动力学基础。

相似文献

1
Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin- dependent N-end rule pathway.多价辅助控制细胞内信号通路:在泛素依赖性N端规则途径中的应用
Chem Biol. 2009 Feb 27;16(2):121-31. doi: 10.1016/j.chembiol.2009.01.012.
2
Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway.靶向N端规则途径识别E3成分的合成异价抑制剂。
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):100-5. doi: 10.1073/pnas.0809681105. Epub 2007 Dec 27.
3
N-end rule specificity within the ubiquitin/proteasome pathway is not an affinity effect.泛素/蛋白酶体途径中的N端规则特异性并非亲和力效应。
J Biol Chem. 2001 Oct 19;276(42):39428-37. doi: 10.1074/jbc.M106967200. Epub 2001 Aug 7.
4
Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway.N端规则途径的泛素连接酶UBR1的底物结合位点。
J Biol Chem. 2008 Aug 29;283(35):24011-28. doi: 10.1074/jbc.M802583200. Epub 2008 Jun 19.
5
The substrate recognition domains of the N-end rule pathway.N端规则途径的底物识别结构域。
J Biol Chem. 2009 Jan 16;284(3):1884-95. doi: 10.1074/jbc.M803641200. Epub 2008 Nov 13.
6
Molecular basis of GID4-mediated recognition of degrons for the Pro/N-end rule pathway.GID4 介导的 Pro/N 端规则途径降解物识别的分子基础。
Nat Chem Biol. 2018 May;14(5):466-473. doi: 10.1038/s41589-018-0036-1. Epub 2018 Apr 9.
7
p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis.p62/SQSTM1/聚集体蛋白1是N端规则途径的一种N识别蛋白,可调节自噬体的生物发生。
Nat Commun. 2017 Jul 24;8(1):102. doi: 10.1038/s41467-017-00085-7.
8
A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.一类包含UBR盒基序并识别N端降解子的哺乳动物E3泛素连接酶家族。
Mol Cell Biol. 2005 Aug;25(16):7120-36. doi: 10.1128/MCB.25.16.7120-7136.2005.
9
Therapeutic strategies within the ubiquitin proteasome system.泛素蛋白酶体系统内的治疗策略。
Cell Death Differ. 2010 Jan;17(1):4-13. doi: 10.1038/cdd.2009.82.
10
Structural basis for the recognition of N-end rule substrates by the UBR box of ubiquitin ligases.泛素连接酶 UBR 盒识别 N 端规则底物的结构基础。
Nat Struct Mol Biol. 2010 Oct;17(10):1175-81. doi: 10.1038/nsmb.1907. Epub 2010 Sep 12.

引用本文的文献

1
Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.利用 AUTOTAC 技术靶向降解帕金森病中的 ⍺-突触核蛋白聚集物。
Mol Neurodegener. 2023 Jun 24;18(1):41. doi: 10.1186/s13024-023-00630-7.
2
On the specificity of protein-protein interactions in the context of disorder.在无序环境下蛋白质-蛋白质相互作用的特异性。
Biochem J. 2021 Jun 11;478(11):2035-2050. doi: 10.1042/BCJ20200828.
3
Binding Revisited-Avidity in Cellular Function and Signaling.再谈结合——细胞功能与信号传导中的亲和力
Front Mol Biosci. 2021 Jan 14;7:615565. doi: 10.3389/fmolb.2020.615565. eCollection 2020.
4
Structural Analyses on the Deamidation of N-Terminal Asn in the Human N-Degron Pathway.结构分析人 N-去稳定化途径中 N 端天冬酰胺的脱酰胺作用。
Biomolecules. 2020 Jan 20;10(1):163. doi: 10.3390/biom10010163.
5
Multivalent Ultrasensitive Interfacing of Supramolecular 1D Nanoplatforms.超分子 1D 纳米平台的多价超灵敏界面作用
J Am Chem Soc. 2019 Nov 13;141(45):18030-18037. doi: 10.1021/jacs.9b05629. Epub 2019 Oct 31.
6
PARK7 modulates autophagic proteolysis through binding to the N-terminally arginylated form of the molecular chaperone HSPA5.PARK7 通过与分子伴侣 HSPA5 的 N 端精氨酸化形式结合来调节自噬蛋白水解。
Autophagy. 2018;14(11):1870-1885. doi: 10.1080/15548627.2018.1491212. Epub 2018 Jul 23.
7
p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis.p62/SQSTM1/聚集体蛋白1是N端规则途径的一种N识别蛋白,可调节自噬体的生物发生。
Nat Commun. 2017 Jul 24;8(1):102. doi: 10.1038/s41467-017-00085-7.
8
Protein Quality Control by Molecular Chaperones in Neurodegeneration.神经退行性变中分子伴侣介导的蛋白质质量控制
Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017.
9
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.胶质瘤来源的癌症干细胞对蛋白酶体抑制高度敏感。
EMBO Rep. 2017 Jan;18(1):150-168. doi: 10.15252/embr.201642360. Epub 2016 Dec 19.
10
The N-end rule pathway.N-端规则途径。
Annu Rev Biochem. 2012;81:261-89. doi: 10.1146/annurev-biochem-051710-093308. Epub 2012 Apr 10.

本文引用的文献

1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.生物系统中的多价相互作用:对多价配体和抑制剂设计与应用的启示
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
2
The substrate recognition domains of the N-end rule pathway.N端规则途径的底物识别结构域。
J Biol Chem. 2009 Jan 16;284(3):1884-95. doi: 10.1074/jbc.M803641200. Epub 2008 Nov 13.
3
The anchor-away technique: rapid, conditional establishment of yeast mutant phenotypes.锚定去除技术:酵母突变体表型的快速、条件性建立。
Mol Cell. 2008 Sep 26;31(6):925-32. doi: 10.1016/j.molcel.2008.07.020.
4
Small-molecule inhibitors of protein-protein interactions.蛋白质-蛋白质相互作用的小分子抑制剂
Curr Opin Drug Discov Devel. 2008 Sep;11(5):666-74.
5
Effects of clustered epitopes in multivalent ligand-receptor interactions.多价配体-受体相互作用中簇状表位的效应
Biochemistry. 2008 Aug 19;47(33):8470-6. doi: 10.1021/bi801208b. Epub 2008 Jul 25.
6
Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway.N端规则途径的泛素连接酶UBR1的底物结合位点。
J Biol Chem. 2008 Aug 29;283(35):24011-28. doi: 10.1074/jbc.M802583200. Epub 2008 Jun 19.
7
Statistical thermodynamics of the stability of multivalent ligand-receptor complexes.多价配体-受体复合物稳定性的统计热力学
Phys Rev Lett. 2008 May 2;100(17):178101. doi: 10.1103/PhysRevLett.100.178101. Epub 2008 Apr 28.
8
Small molecular weight protein-protein interaction antagonists: an insurmountable challenge?小分子蛋白质-蛋白质相互作用拮抗剂:一项难以克服的挑战?
Curr Opin Chem Biol. 2008 Jun;12(3):281-91. doi: 10.1016/j.cbpa.2008.04.603. Epub 2008 May 21.
9
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.F-box蛋白SKP2和β-TrCP介导的蛋白水解失调:影响癌症的平衡
Nat Rev Cancer. 2008 Jun;8(6):438-49. doi: 10.1038/nrc2396.
10
Joining the army of proteasome inhibitors.加入蛋白酶体抑制剂大军。
Chem Biol. 2008 May;15(5):419-21. doi: 10.1016/j.chembiol.2008.04.010.